What does Entrada Therapeutics, Inc. (TRDA) do?

Entrada Therapeutics, Inc. (TRDA) is a publicly traded company in the Healthcare sector.

What sector does TRDA operate in?

Entrada Therapeutics, Inc. operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TRDA earnings analysis?

AlphaOS publishes an earnings intelligence page for Entrada Therapeutics, Inc. (TRDA) covering results, guidance context, and AI-assisted analysis. See /stocks/TRDA/earnings. Content is for research and education — not investment advice.

Coverage building

TRDA has basic price and filing data (35% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 35%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TRDA

Entrada Therapeutics, Inc.

Healthcare · Pharmaceutical Preparations

$6.26Sep 29, 2026

AI confidence 58% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Entrada Therapeutics, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -54% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -54% YoY in Q2 FY2026

Pipeline evidence · 0d ago

TRDA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TRDA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TRDA earnings analysis

Reported figures for Entrada Therapeutics, Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Entrada Therapeutics, Inc. (TRDA) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 29, 2026 at $6.26.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Entrada Therapeutics, Inc. (TRDA)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Entrada Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $243.74M
Revenue:: $25.42M

TRDA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Entrada Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.